Frost & Sullivan Acknowledges That PKC's Biosensors Are Expected To Become The New Industry Standard In Pathogen Testing
MOUNTAIN VIEW, Calif., Feb. 13, 2013 /PRNewswire/ -- Based on its recent analysis of the global biosensors market, Frost & Sullivan recognizes Pharmaco-Kinesis Corporation (PKC) with the 2013 Global Frost & Sullivan Award for New Product Innovation. The company has set a new standard in the biosensors market with its innovative, highly sensitive biosensor. This unique, multi-pathogen detection device utilizes electrochemical impedance spectroscopy (EIS) to detect pathogens such as E. coli 0157:H7 and the severe acute respiratory syndrome (SARS) virus. It offers higher sensitivity, accuracy, cost-savings. Other key advantages are its greater portability and reusability; and a shorter, less complex testing process than other biosensors in the market. This exhibits PKC's market expertise and technological excellence.
PKC biosensors' sample preparation is conducted in a controlled environment, which eliminates the possibility of contamination. Additionally, PKC biosensors require minimal human intervention and provide immediate, real-time pathogen detection. The product has a longer lifespan than similar solutions and can operate efficiently for more than five years with repeated use.
Unlike other pathogen test instruments that utilize test strips or incubators, PKC biosensors use a biosensor container with an electrochemical sensor attached to the base, along with a liquid mixer and a microprocessor that records biosensor readings. This entire device is encased in protective housing, which includes a container holder. This technology lets the pathogen detection status be obtained remotely in real time using radio frequency identification (RFID) readers.
"PKC's new biosensor offers a number of advantages over the other pathogen test solutions in the market. For example, the lateral flow method requires about eight hours for sample preparation and testing, while PKC's new technology takes only four hours," said Frost & Sullivan Research Analyst Dr. Rajender Thusu. "Further, PKC's technology can detect E. coli 0157:H7, even when it is present in colonies of hundreds, a considerably smaller population than required by other test methods."Additionally, PKC's technology requires a consumable input of only bacteria culture medium, which makes this solution highly cost-effective. Using a vertical orientation of colonies, instead of existing test solutions' horizontal orientation, significantly accelerates the detection process.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts